AZD3759

· LYZZ Alpha Holding Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD3759, covering 2022-11-25 to 2022-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759 [Phase 1, Phase 2]